Neuroscience Team Recognized as Unit of Distinction

Translate to Spanish or other 102 languages!

Colleagues from RGRH’s Critical Care - Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH
Colleagues from RGRH’s Critical Care – Progressive Care Unit, Recipient of HCA Healthcare’s the Neuroscience Unit of Distinction. Courtesy Photo RGRH

Mega Doctor News

- Advertisement -

McALLEN, Texas – Rio Grande Regional Hospital (RGRH) is proud and excited to announce that the Neuroscience team was recently recognized as a Recipient of the HCA Healthcare Critical Care – Progressive Care Unit of Distinction.  A total of 202 nursing units from across the country were recognized as top-performing nursing units. 

Units of Distinction are categorized in the top five percent of all HCA Healthcare medical-surgical, critical care, emergency services, surgical services, behavioral health, women’s and children’s nursing units, pediatrics/PICU, and inpatient rehabilitation units.  The top six to 10  percent of all HCA Healthcare units earned honorable mention designations. Our quality of care includes a multidisciplinary approach that consists of emergency room physicians, vascular-trained neurologists available 24-7, neurosurgeons, cardiologists, and an excellent rehabilitation team. 

Congratulations to the Neuroscience team for raising the bar and for their continued commitment to our mission, “Above all else, we are committed to the care and improvement of human life.”  

- Advertisement -

To learn more about the Stroke and Neurosciences programs, visit RioHealth.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Heart Earns Healthgrades Five-Star Rating for Pacemaker Procedures

Healthgrades, the leading online resource for information about physicians and hospitals, has named STHS Heart a Five-Star Recipient for Pacemaker Procedures in 2027 for the second consecutive year, recognizing the facility's superior clinical outcomes and commitment to patient care.

AMA Advises Patients to Check with Doctors on Web Advice

The internet offers no shortage of health advice. But with misleading medical claims spread across social media, search engines, and AI platforms, finding trustworthy answers can be a challenge. 

FDA Authorizes Focused Ultrasound Treatment for Varicose Veins

Theraclion has announced that the US Food and Drug Administration (FDA) has granted De Novo authorization for its Sonovein device to treat superficial venous reflux in great saphenous veins (GSV), the main cause of varicose veins. This is the first noninvasive focused ultrasound platform to treat varicose veins, which affect approximately one third of adults.

Identify the Early Warning Signs of Memory Loss

We’ve all lost our keys or forgotten a name every now and then, but when does forgetfulness signal something more serious?
- Advertisement -